| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/1996 | WO1996021670A3 Antifungal fusacandins |
| 09/12/1996 | WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 09/12/1996 | WO1996020199A3 Diclavulanate salt with a diamino ether and process of preparation |
| 09/12/1996 | WO1996016677A3 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography |
| 09/12/1996 | DE19508827A1 Wund- und Schleimhautantiseptikum Wound and mucosa |
| 09/12/1996 | CA2214776A1 Antitumour isocoumarins |
| 09/12/1996 | CA2214726A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | CA2214583A1 Indole derivatives as eaa antagonists |
| 09/12/1996 | CA2214379A1 Compositions for the treatment of blood disorders |
| 09/12/1996 | CA2214126A1 Stimulation of meiosis |
| 09/12/1996 | CA2213000A1 Reduction of infarct volume using citicoline |
| 09/12/1996 | CA2187917A1 Gentle anti-acne composition |
| 09/11/1996 | EP0731101A1 3-Benzyl-benzothiophenes |
| 09/11/1996 | EP0731100A1 Benzothiophene pharmaceutical compounds |
| 09/11/1996 | EP0731099A1 N-(3-benzofuranyl)urea-derivatives |
| 09/11/1996 | EP0731098A1 Alpha-substituted-3-benzyl-benzofurans |
| 09/11/1996 | EP0731097A1 Novel benzofuran pharmaceutical compounds |
| 09/11/1996 | EP0731093A1 Naphthyl pharmaceutical compounds |
| 09/11/1996 | EP0731088A2 Retroviral protease inhibitors |
| 09/11/1996 | EP0731078A1 Terpene-quinone with antitumor activity |
| 09/11/1996 | EP0730869A1 Biodegradable medicinal polymer assembly with supermolecular structure |
| 09/11/1996 | EP0730867A2 Non-animal polyanions for use in dermatology and cosmetics |
| 09/11/1996 | EP0730866A2 Treatment of optic nerve disorders with prostanoic acid compounds |
| 09/11/1996 | EP0730865A1 Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease |
| 09/11/1996 | EP0730864A1 Medicament for treating cardiac inflammatory disease |
| 09/11/1996 | EP0730863A2 A corneal opacification inhibitory composition comprising a fumagillol derivative |
| 09/11/1996 | EP0730862A1 Formulation containing glucaric acid for the prevention or treatment of non-cancerous cellular hyperproliferation and dietary supplement |
| 09/11/1996 | EP0730861A1 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions |
| 09/11/1996 | EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 09/11/1996 | EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 09/11/1996 | EP0730601A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 09/11/1996 | EP0730598A1 Hindered esters of rapamycin and their use as pharmaceuticals |
| 09/11/1996 | EP0730597A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 09/11/1996 | EP0730596A1 Benzodiazepines |
| 09/11/1996 | EP0730595A1 Imidazolinobenzodiazepines |
| 09/11/1996 | EP0730594A1 NOVEL 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES |
| 09/11/1996 | EP0730591A1 Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 09/11/1996 | EP0730590A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 09/11/1996 | EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 09/11/1996 | EP0730587A1 3-aryl-2-isoxazolines as antiinflammatory agents |
| 09/11/1996 | EP0730584A1 3-acylaminobenzodiazepines |
| 09/11/1996 | EP0730581A1 3-acylaminobenzazepines |
| 09/11/1996 | EP0730579A1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 09/11/1996 | EP0730578A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
| 09/11/1996 | EP0730577A1 26,28-methylene-1alpha,25-dihydroxyvitamin d 2 compounds |
| 09/11/1996 | EP0730576A1 Novel carbamate compounds and processes for preparing the same |
| 09/11/1996 | EP0730575A1 Novel carbamate compounds and processes for preparing the same |
| 09/11/1996 | EP0730571A1 Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors |
| 09/11/1996 | EP0730474A1 Estramustine formulations with improved pharmaceutical properties |
| 09/11/1996 | EP0730467A1 Inhibitors of farnesyl-protein transferase |
| 09/11/1996 | EP0730464A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex |
| 09/11/1996 | EP0730463A1 Use of lithium compounds in the treatment and prevention of alzheimer's disease |
| 09/11/1996 | EP0730462A1 Condensation polymer of an aromatic sulfonic acid and an aldehyde for inhibiting hiv infectivity |
| 09/11/1996 | EP0730461A1 The use of an ester of inositoltrisphosphate for the preparing of an analgetic medicament |
| 09/11/1996 | EP0730460A1 The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions |
| 09/11/1996 | EP0730459A1 The use of an ester of inositoltrisphosphate for the preparing of medicaments |
| 09/11/1996 | EP0730458A1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 09/11/1996 | EP0730457A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri |
| 09/11/1996 | EP0730456A1 Antiarrhythmic benzodiazepines |
| 09/11/1996 | EP0730455A1 Antiarrhythmic benzodiazepines |
| 09/11/1996 | EP0730454A1 Antiarrhythmic benzodiazepines |
| 09/11/1996 | EP0730453A1 Methods of treating cardiac arrhythmia |
| 09/11/1996 | EP0730452A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 09/11/1996 | EP0730451A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 09/11/1996 | EP0730450A1 Plaster for treating nail mycoses |
| 09/11/1996 | EP0730448A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor |
| 09/11/1996 | EP0730447A1 Fatty acid delivery system |
| 09/11/1996 | EP0730446A1 Protein kinase c activators and their use in decreasing expression of cell antigens |
| 09/11/1996 | EP0730445A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors |
| 09/11/1996 | EP0730444A1 Sustained release formulations for 24 hour release of metoprolol |
| 09/11/1996 | EP0730443A1 Suspension of loteprednol etabonate |
| 09/11/1996 | EP0730441A1 Desquamation compositions containing salicylic acid and zwitterionic compounds |
| 09/11/1996 | EP0730439A1 Compositions comprising iminium ion scavengers and/or nitrite scavengers |
| 09/11/1996 | EP0730408A1 Triazole phosphonate pesticides |
| 09/11/1996 | EP0614366B1 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours |
| 09/11/1996 | EP0591252B1 Thiazolidinedione hypoglycemic agents |
| 09/11/1996 | EP0581926B1 Animal feedstuff for growth increase |
| 09/11/1996 | EP0559677B1 Hydroxamic acids for preventing reperfusion injury |
| 09/11/1996 | EP0542952B1 Use of 1-(beta-d-arabinofuranosyl)-5-propynyluracil for lowering serum cholesterol |
| 09/11/1996 | EP0528950B1 Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders |
| 09/11/1996 | EP0513379B1 2-arylthiazole derivative and pharmaceutical composition containing the same |
| 09/11/1996 | EP0507861B1 Diaromatic substituted anti-aids compounds |
| 09/11/1996 | EP0484395B1 Method of preventing graft rejection in solid organ transplantation |
| 09/11/1996 | EP0450066B1 Carbostyril derivatives |
| 09/11/1996 | CN1130909A 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents |
| 09/11/1996 | CN1130907A Process for preparation of indolizine derivatives |
| 09/11/1996 | CN1130906A Oxathiolanes, method for their preparation and pharmaceutical compositions containing same |
| 09/11/1996 | CN1130905A Process for making HIV protease inhibitors |
| 09/11/1996 | CN1130904A Substituted pyridines and pyrimidines, process for producing them and their use as pesticides and fungicides |
| 09/11/1996 | CN1130903A Condensed 1,2-indene dihydride and its salt for medicine |
| 09/11/1996 | CN1130902A Substituted pyridines, process for producing them and their use as pesticides and fungicides |
| 09/11/1996 | CN1130899A Novel structural analogues of vitamin D |
| 09/11/1996 | CN1130898A Difluoro statone antiviral analogs |
| 09/11/1996 | CN1130875A Cosmetic compositions |
| 09/11/1996 | CN1130874A Method of treating liver disease and like indications with vasodilating agents |
| 09/11/1996 | CN1130873A Method of treating HIV with azaspiranes |
| 09/11/1996 | CN1130872A Use of benzydamine in treatment of pathological conditions caused by TNF |
| 09/11/1996 | CN1130871A Method of inhibiting replication of human immunodeficiency viruses with substituted azaspiranes |
| 09/11/1996 | CN1130870A Method of inhibiting production of human immunodeficiency viruses with substituted azaspiranes |
| 09/11/1996 | CN1130866A Anti-angiogenic compositions and method of use |